Smoking behavior and risk of Helicobacter pylori infection, gastric atrophy and gastric cancer in Japanese

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 2, 2010, Pages 313-317

  Hishida, Asahi ^a   Matsuo, Keitaro ^b   Goto, Yasuyuki ^a   Naito, Mariko ^a   Wakai, Kenji ^a   Tajima, Kazuo ^b   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Gastric atrophy; Gastric cancer; H. pylori infection; Lifestyle factors; Smoking

Indexed keywords

EID: 78650702097     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Azuma T (2004). Helicobacter pylori CagA protein variation associated with gastric cancer in Asia. J Gastroenterol, 39, 97-103.
2. Biemond I, Kreuning J, Jansen JB, et al. (1994). Serum pepsinogens in patients with gastric diseases or after gastric surgery. Scand J Gastroenterol, 29, 238-42.
3. Buiatti E, Muñoz N, Kato I, et al. (1996). Determinants of plasma anti-oxidant vitamin levels in a population at high risk for stomach cancer. Int J Cancer, 65, 317-22.
4. Craanen ME, Dekker W, Blok P, et al. (1992). Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut, 33, 16-20.
5. Dyke GW, Craven JL, Hall R, et al. (1992). Smoking-related DNA adducts in human gastric cancers. Int J Cancer, 52, 847-50.
6. IARC (1994). IARC monographs on the evaluation of carcinogenic risks to humans. Vol 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC.
7. Kato I, Vivas J, Plummer M, et al. (2004). Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev, 13, 468-76.
8. Hamajima N, Naito M, Kondo T, et al. (2006). Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci, 97, 1129-38.
9. Hishida A, Matsuo K, Goto Y, et al. (2009a). Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese. BMC Gastroenterol, 9, 51.
10. Hishida A, Matsuo K, Goto Y, et al. (2009b). Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobacter, 14, 47-53.
11. Inoue M, Kobayashi S, Matsuura A, et al. (1998). Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis. Cancer Epidemiol Biomarkers Prev, 7, 261-3.
12. Ito Y, Azuma T, Ito S, et al. (1997). Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol, 35, 1710-4.
13. Ito LS, Oba-Shinjo SM, Marie SK, et al. (2003). Lifestyle factors associated with atrophic gastritis among Helicobacter pylori-seropositive Japanese-Brazilians in São Paulo. Int J Clin Oncol, 8, 362-8.
14. Miki K, Ichinose M, Shimizu A, et al. (1987). Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn, 22, 133-41.
15. Mirvish SS (1995). Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett, 93, 17-48.
16. Oksanen A, Sipponen P, Miettinen A, et al. (2000). Evaluation of blood tests to predict normal gastric mucosa. Scand J Gastroenterol, 35, 791-5.
17. Parkin DM, Pisani P, Ferlay J (1999). Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 80, 827-41.
18. Sasazuki S, Inoue M, Iwasaki M, et al. (2006). Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Cancer Epidemiol Biomarkers Prev, 15, 1341-7.
19. Shikata K, Doi Y, Yonemoto K, et al. (2008). Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol, 168, 1409-15.
20. Shimoyama T, Everett SM, Fukuda S, et al. (2001). Influence of smoking and alcohol on gastric chemokine mRNA expression in patients with Helicobacter pylori infection. J Clin Pathol, 54, 332-4.
21. Sipponen P, Järvi O, Kekki M, et al. (1987). Decreased incidences of intestinal and diffuse types of gastric carcinoma in Finland during a 20-year period. Scand J Gastroenterol, 22, 865-71.
22. Suzuki T, Matsuo K, Ito H, et al. (2006). Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med, 119, 217-24.
23. Suzuki H, Hibi T, Marshall BJ (2007). Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol, 42, 1-15.
24. Tajima K, Hirose K, Inoue M, et al. (2000). A model of practical cancer prevention for out-patients visiting a hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Asian Pac J Cancer Prev, 1, 35-47.
25. Yanaoka K, Oka M, Mukoubayashi C, et al. (2008). Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev, 17, 838-45.
26. Yoneyama H, Katsumata R (2006). Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci Biotechnol Biochem, 70, 1060-75.